Searched for
SANOFI GROUP
CD&R makes Rs 2,983 cr open offer for 26% stake in Sanofi Consumer Healthcare IndiaGlobal investment firm CD&R announces an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India for up to Rs 2,983 crore. Th...- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- French drugmaker Sanofi looks to spin off its consumer business in IndiaThe leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...
- Sanofi names Rodolfo Hrosz as India unit headHrosz will transition from being Sanofi’s general manager, Consumer Healthcare business in Brazil to his new role in India as soon as the a...
- Sanofi India's managing director Rajaram Narayanan steps down"In these roles, he has led the strategic reorientation of the organisation, sharpening its focus on core areas, developing new business mo...
- Encube Ethicals to buy Soframycin for Rs 125 crore for India & SL marketsEncube Ethicals has agreed to buy popular topical anti-microbial brand Soframycin and other brands from French drugmaker Sanofi for India a...
- Sanofi and GSK launch trial for COVID-19 protein-based vaccineSanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which th...
- India waives large-scale clinical trials for Sanofi's dengue vaccineAn expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine develope...
- Sanofi picks 20% stake in Apollo Sugar Clinics for Rs 90 croreThe investment will be made by Sanofi-Synthelabo India "through a combination of primary and secondary funding," Apollo Hospitals said.
- CCI gives green signal to Sanofi-Apollo dealUnder the proposed deal, Sanofi-Synthelabo would acquire 20 per cent stake and exercise certain rights in relation to management of Apollo ...
- L'Oreal's Sanofi stake a 'reserve' for takeovers, says Jean-Paul Agon, CEOJean-Paul Agon added that L'Oreal would not shrink from a larger takeover, but such a deal would have to make sense and be affordable.
- Sanofi inks pact with Suzlon for captive power plantDrug firm Sanofi India today said it has inked a pact with Suzlon Energy for a 2.1 megawatt windmill installation.
- Sanofi India to use renewable energy for its Ankleshwar manufacturing siteSanofi India announced that it has signed an agreement with India's largest wind turbine manufacturer, SEL, for a 2.1 MW offsite windmill i...
- Sanofi charts India-specific strategy to boost shareFrench drug maker Sanofi says it is considering an India-specific strategy to increase its share in the country’s Rs 65,000-crore drug mark...
- Taxman summons Shanta Biotech top brass on Sanofi deal; Sanofi may challenge retro tax lawsIncome tax authorities summoned the management of Hyderabad based Shanta Biotechnics in connection with an outstanding tax demand of Rs 105...
- Aventis Pharma renamed as Sanofi IndiaThe shareholders of the company had earlier approved the name change at the annual general meeting held on May 3, a company statement said.
- Aventis to acquire Universal Medicare's nutraceutical bizAventis Pharma said it will acquire the branded nutraceutical formulations business of Mumbai-based Universal Medicare Pvt Ltd.
- Sanofi extends bid for GenzymeFrench pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving the off...
- Shantha bags over Rs 1,600 crore order from UnicefHyderabad-based Shantha Biotechnics has bagged a USD 340 million (around Rs 1,650 crore) order from Unicef to supply its 'SHAN5', a combina...
- Sanofi arm may make India global output hub for vaccinesIndia may be a possible location as a global manufacturing base for vaccines business of Sanofi-Aventis Group.
Load More
